Mineralocorticoid Receptor Antagonists for Aldosterone-Mediated Disorders
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hypertension and heart failure are suboptimal, and there is a need for additional therapeutic interventions to address aldosterone-mediated disorders, including cardiovascular diseases and other aldosterone-related conditions.
Innovation Solution
Development of compounds with Mineralocorticoid Receptor (MR) antagonist activity, specifically represented by Formula I, which are useful for treating and preventing aldosterone-mediated disorders by antagonizing the aldosterone receptor.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current standard treatments for hypertension and heart failure are used, then existing therapeutic effects are achieved, but treatment effectiveness is suboptimal and additional therapeutic interventions are needed
Solution Approach 1:
The patent modifies the molecular structure of mineralocorticoid receptor antagonists by changing chemical parameters (introducing specific substituents at defined positions in the molecular framework) to enhance therapeutic effectiveness and expand treatment options for aldosterone-mediated disorders
Solution Approach 2:
The invention creates composite molecular structures combining specific pharmacological moieties with various substituent groups to achieve optimized binding affinity and selectivity for the mineralocorticoid receptor, thereby improving treatment effectiveness
2Reliability
If mineralocorticoid receptor antagonists are developed with specific molecular structures, then therapeutic efficacy is improved, but compound complexity increases
Solution Approach 1:
The patent divides the molecular structure into a core framework and multiple substituent positions, allowing systematic modification of specific segments to achieve desired therapeutic properties while maintaining overall structural manageability
Solution Approach 2:
The invention introduces specific functional groups and substituents at particular local positions within the molecular structure to optimize binding affinity and selectivity without requiring complex modifications throughout the entire molecule
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively treat and prevent hypertension, heart failure, cardiovascular disorders, and other aldosterone-related conditions by antagonizing the MR, providing a therapeutic option for conditions such as hypertension, heart failure, and metabolic syndrome.
Implementation Method 1
The present invention relates to compounds which have Mineralocorticoid Receptor (MR) antagonist activity... which effectively treat and prevent hypertension, heart failure, cardiovascular disorders... by antagonizing the MR
Data Source
AI summary
Compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosterone-mediated diseases are disclosed. Processes for preparing compounds of the Formula (I), use of the compounds for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and pharmaceutical compositions which comprise compounds of the Formula (I) are disclosed.